文献速递颈动脉与弓上血管

吸烟状态预测症状性颈动脉狭窄内膜剥脱术后死亡率,但支架或经颈动脉血运重建术后无此关联

Smoking Status Predicts Mortality after Carotid Endarterectomy for Symptomatic Disease but Not after Carotid Stenting or Transcarotid Revascularization.
PubMed 文献 · Ann Vasc Surg · 2026-03-27

基于VQI数据库2003至2021年27,693例症状性颈动脉狭窄干预患者,倾向匹配后分析吸烟状态与死亡率的关系。CEA术后活动性吸烟者1年死亡率显著高于从不吸烟者(5.43% vs 3.78%,P=0.005)和既往吸烟者(5.73% vs 4.57%,P=0.012),而TFCAS或TCAR术后死亡率无吸烟相关差异。多因素分析显示活动性吸烟(OR 1.395,95%CI 1.11-1.67)和既往吸烟(OR 1.321,95%CI 1.12-1.56)均为CEA术后1年死亡率的独立预测因素。

要点

  • CEA术后活动性吸烟者1年死亡率显著高于从不吸烟者(5.43% vs 3.78%,P=0.005)。
  • CEA术后活动性吸烟者1年死亡率高于既往吸烟者(5.73% vs 4.57%,P=0.012)。
  • TFCAS或TCAR术后死亡率未显示与吸烟状态相关。

核心结论

  • 活动性和既往吸烟均与CEA治疗症状性颈动脉狭窄后1年死亡率升高独立相关。
  • TFCAS或TCAR术后未观察到吸烟状态与死亡率的关联。
  • 活动性吸烟者1年死亡率高于既往吸烟者,强调颈动脉疾病患者戒烟的重要性。

研究设计与样本

  • 回顾性队列研究,基于Vascular Quality Initiative数据库2003至2021年数据。
  • 纳入27,693例因症状性颈动脉狭窄接受CEA(18,867例)、TFCAS(5,388例)或TCAR(3,438例)的患者。
  • 按从不吸烟、既往吸烟(术前戒烟≥1个月)和活动性吸烟(1个月内吸烟)分组,采用倾向评分匹配调整人口学、合并症、术前用药等因素。

主要发现

  • CEA术后活动性吸烟者30天死亡率与从不吸烟者无显著差异(1.19% vs 0.89%,P=0.338)。
  • CEA术后活动性吸烟者1年死亡率显著高于从不吸烟者(5.43% vs 3.78%,P=0.005)和既往吸烟者(5.73% vs 4.57%,P=0.012)。
  • TFCAS或TCAR术后死亡率按吸烟状态无显著差异。
  • TCAR术后既往吸烟者总体并发症发生率高于从不吸烟者(8.27% vs 5.19%,P=0.041),其他次要结局无显著差异。
  • 多因素logistic回归显示活动性吸烟(OR 1.395,95%CI 1.11-1.67)和既往吸烟(OR 1.321,95%CI 1.12-1.56)预测CEA术后1年死亡率。

临床怎么用

  • 对接受CEA的症状性颈动脉狭窄患者,应评估吸烟状态并强调戒烟以降低远期死亡风险。
  • 选择TFCAS或TCAR时,吸烟状态对术后死亡率的预测价值不显著,但仍需个体化评估。

局限性

  • 回顾性数据库研究可能存在未测量混杂。
  • 吸烟状态依赖数据库记录,可能存在错分。
  • 仅纳入VQI参与中心,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the impact of smoking on mortality after interventions for symptomatic carotid stenosis. METHODS: The Vascular Quality Initiative database was reviewed from 2003 to 2021 to identify patients undergoing interventions for symptomatic carotid artery stenosis with carotid endarterectomy (CEA), transfemoral carotid stenting (TFCAS), or transcarotid artery revascularization (TCAR). Patients were grouped as never, former (quit ≥1 month prior), or active smokers (smoking within 1 month). Propensity matching adjusted for demographics, comorbidities, preoperative medications, and additional risk factors. Primary outcomes were 30-day and 1-year mortality; secondary outcomes included 30-day transient ischemic attack, stroke, and other complications. Multivariate logistic regression identified independent predictors of mortality. RESULTS: We identified 27,693 patients who underwent carotid artery interventions for symptomatic stenosis (CEA = 18,867; TFCAS = 5,388; TCAR = 3,438). After propensity score matching, no significant differences persisted in preoperative demographics and risk factors. After CEA, active smokers exhibited similar rates of 30-day mortality (1.19% vs. 0.89%, P = 0.338), but significantly higher rates of 1-year mortality (5.43% vs. 3.78%, P = 0.005) compared to never smokers. Active smokers also had an increased rate of 1-year mortality compared to former smokers (5.73% vs. 4.57%, P = 0.012). Mortality did not differ by smoking status after TFCAS or TCAR. There was an increased rate of overall complications in former smokers over never smokers undergoing TCAR (8.27% vs. 5.19%, P = 0.041), otherwise no other significant differences were noted in any of the secondary outcomes. On multivariate logistic regression analysis, both active smoking (odds ratio 1.395, 95% confidence interval: 1.11-1.67) and former smoking (odds ratio 1.321, 95% confidence interval: 1.12-1.56) were predictive of 1-year mortality following CEA. CONCLUSION: Both active and former smoking are independently associated with increased 1-year mortality following CEA for symptomatic carotid artery stenosis, but not after TFCAS or TCAR. Active smoking was associated with higher 1-year mortality than former smoking, highlighting the importance of smoking cessation in patients with carotid disease.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Basilious M, Akosman I, Sarad N, et al. Smoking Status Predicts Mortality after Carotid Endarterectomy for Symptomatic Disease but Not after Carotid Stenting or Transcarotid Revascularization. Ann Vasc Surg. 2026. PMID: 41903843. doi:10.1016/j.avsg.2026.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。